Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and ComorbiditiesSteven Lim, Sangeetha Jaya Selan, Wee Kooi Cheah et al.|JAMA Internal Medicine|2022Cited by 105
Risk of serious adverse events after the BNT162b2, CoronaVac, and ChAdOx1 vaccines in Malaysia: A self-controlled case series studyNorazida Ab Rahman, Kalaiarasu M. Peariasamy, Ming Tsuey Lim et al.|Vaccine|2022Cited by 41
Thrombocytopenia and venous thromboembolic events after BNT162b2, CoronaVac, ChAdOx1 vaccines and SARS-CoV-2 infection: a self-controlled case series studyNorazida Ab Rahman, Nor Azizah Mohamad Nazri, Ming Tsuey Lim et al.|Scientific Reports|2023Cited by 6
Risk of major adverse cerebro-cardiovascular events following BNT162b2, CoronaVac, and ChAdOx1 vaccination and SARS-CoV-2 infection: A self-controlled case-series studyNorazida Ab Rahman, Sheamini Sivasampu, Teck Long King et al.|Vaccine|2024Cited by 4